HOME >> BIOLOGY >> NEWS
Virus linked to Thoroughbred abortion epidemic

CORVALLIS, Ore. A new study by veterinary researchers at Oregon State University has linked a major epidemic of abortion a few years ago in Kentucky Thoroughbred mares to infection with vesivirus, the first time the virus has been suggested to cause this type of problem in horses.

The findings, which were just published in the American Journal of Veterinary Research, add another concern to the health issues associated with this virus, which is a part of the Caliciviridae viral family that can infect and cause health problems in many animal species, including humans.

About five years ago, mares in Kentucky's billion dollar Thoroughbred industry were losing foals at an alarming rate, with abortions of unknown cause happening up to 10 times more than usual on some farms. The problem eventually dissipated, and researchers since then have worked to identify the cause.

Many agents known to cause abortion in horses were considered at the time and ultimately dismissed, but some studies suggested at least part of the problem might be exposure to toxins in Eastern tent caterpillars found on some farms.

One new study examined 112 horses, both normal and those that had suffered abortions. It found that 40 percent of the mares with no reported abortion problems tested positive for vesivirus antibodies, but 64 percent of those from areas with high rates of abortion, or that had aborted their foals, had vesivirus exposure. All male horses and younger females not of breeding age tested negative for vesivirus antibodies.

According to researchers, these data suggest that vesivirus must now be considered a pathogenic virus associated with abortion in mares. It indicates that broodmares are being commonly exposed to vesivirus from unknown sources, they said, and that vesiviruses should be added to the panel of diagnostic tests for horses that abort.

It is not known whether exposure to horses, especially broodmares that abort, is a
'"/>

Contact: Dr. Alvin Smith
calicit@qwest.net
541-745-0707
Oregon State University
22-Jun-2006


Page: 1 2 3

Related biology news :

1. Virus widely used in gene therapy research yields important clues to genomic instability
2. The sweet science: Viruses switch grip to gain upper hand
3. Virus may control Australias "river rabbit"
4. Viruses can jump between primates and humans, researchers warn
5. Virus has catastrophic affect on red squirrels, research shows
6. Smooth sailing: Cruise Ship Virus tackled by UH, Baylor College of Medicine
7. New strategy developed to combat West Nile Virus
8. Virus chip detects new virus in prostate tumors
9. Secrets to antibodys success against West Nile Virus surprise scientists
10. Virus uses tiny RNA to evade the immune system
11. Virus-host interactions at sea effect global photosynthesis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Virus linked Thoroughbred abortion epidemic

(Date:3/30/2015)... 26, 2015 Research and Markets ( ... "Global Gesture Recognition Market in Automotive Sector 2014-2018" ... the Global Gesture Recognition market in Automotive Sector to ... 2013-2018. Gesture recognition is the ability of ... of an individual. Gesture recognition technology can be 2D-based ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... with critical security-authentication needs, today announced the beginning of ... (FFD) solution. The company, based in ... at the three-day Connect:ID Expo, which began here today ... NexID said version 2.0 of its SDK boosts the ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
(Date:4/30/2015)... - BioAmber Inc. (NYSE: BIOA ), an industrial ... commenced an underwritten public offering of its common stock.  ... 30-day option to purchase up to an additional 15 ... the public offering. The offering is subject to market ... whether or when the offering may be completed, or ...
(Date:4/30/2015)... MA & Budapest, Hungary (PRWEB) April 30, 2015 ... only web-based electronic lab notebook with integrated protocols ... in providing chemistry software solutions and consulting services ... led to the development of Labguru’s newest feature: ... set of deep domain features for biologists, bio-chemists, ...
(Date:4/30/2015)... DUBLIN , April 30, 2015 ... a Leading Global Biotechnology Company   ... results for the three months to March 31, 2015. ... Product sales $1,423 million +9% +13% Total revenues $1,488 ... +16% +19% US GAAP operating income from continuing operations ...
(Date:4/30/2015)... 2015 SureClinical, a leader in cloud-based ... has joined SureClinical’s executive team as Chief Financial Officer. ... technology executive with over 25 years in leadership roles ... , Ms. Morris joins SureClinical from Marrone Bio Innovations ... CFO of MBI from its founding in 2006 until ...
Breaking Biology Technology:BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3Labguru Integrates ChemAxon's Marvin JS, to Enhance Functionality for Chemists 2Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 2Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 3Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 4Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 5Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 6Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 7Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 8Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 9Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 10Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 11Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 12Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 13Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 14Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 15Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 16Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 17Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 18Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 19Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 20Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 21Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 22Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 23Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 24Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 25Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 26Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 27Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 28Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 29Julie I. Morris Joins SureClinical as Chief Financial Officer 2
Cached News: